A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Cenobamate Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this Phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group, adjunctive therapy study is to evaluate the safety, efficacy, and pharmacokinetics of cenobamate adjunctive therapy in subjects with primary generalized tonic-clonic (PGTC) seizures.
Details
| Condition | Primary Generalized Tonic-Clonic Seizures |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX10440 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.